0

Marine Pharmaceuticals Market by Product and Geography - Forecast and Analysis 2022-2026

  • Published: May 2022
  • Pages: 135
  • SKU: IRTNTR70227
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

Based on Technavio's market sizing methodology, the marine pharmaceuticals market size is predicted to surge by USD 1.56 billion from 2021 to 2026 at a CAGR of 7.73%.

This report entails marine pharmaceuticals market segmentations, including:

  • Product - Oncology, cardiovascular, anti-infectives, and others
  • Geography - North America, Europe, Asia, and Rest of World (ROW)

This marine pharmaceuticals market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The marine pharmaceuticals market report offers information on several market vendors, including Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc among others.

What will the Marine Pharmaceuticals Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Marine Pharmaceuticals Market Size for the Forecast Period and Other Important Statistics

 

Marine Pharmaceuticals Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The licensing agreements is notably driving the marine pharmaceuticals market growth, although factors such as the regular supply of marine organisms and compounds may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the marine pharmaceuticals industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Marine Pharmaceuticals Market Driver

  • The licensing agreements is one of the key drivers supporting the marine pharmaceuticals market size growth.
  • The licensing agreements in the global marine pharmaceuticals market enable the company to expand the reach of the product to multiple nations with relatively less involvement and risk.
  • For instance, PharmaMar has a licensing agreement with Boryung Pharm for Zepsyre (lurbinectedin) in South Korea. The licensing agreement will enable the entry of Zepsyre into the South Korean market. I
  • Another licensing and marketing agreement took place in the global marine pharmaceuticals market between PharmaMar and STA. This agreement involves lurbinectedin, which is an anti-tumor compound under clinical investigation.
  • The agreement with Singapore-based STA will allow the entry of lurbinectedin into Australia, New Zealand, and several Asian countries. These licensing agreements will help in increasing the availability of marine pharmaceuticals across the regions, which, in turn, will drive the global marine pharmaceuticals market growth during the forecast period. 

Key Marine Pharmaceuticals Market Trend

  • Marine peptides as anti-infectives is one of the key marine pharmaceuticals market trends fueling the market growth.
  • The interest of researchers in evaluating the potential of peptides from marine sources as anti-infective agents has increased.
  • Marine-derived peptides are specific fragments of protein that act as sources of nitrogen and amino acids and possess various potential physiological functions.
  • The primary sources of the peptides include fish, algae, crab, marine bacteria, and fungus.
  • Marine peptides can lead to the discovery of new anti-infectives to cater to the demand for new and efficacious antimicrobial compounds. This, in turn, will drive the marine pharmaceuticals market size growth during the forecast period.

Key Marine Pharmaceuticals Market Challenge

  • The regular supply of marine organisms and compounds is one of the challenges hampering the marine pharmaceuticals market size growth.
  • For instance, sponges produce a large number of bioactive metabolites. It is interpreted that bioactive metabolites serve as a chemical defense to combat environmental stress factors leading to competition for space and predation. 
  • The hurdles in the regular supply of raw materials required for a marine pharmaceutical product include the non-availability of efficient technology for the extraction of marine compounds as they are usually found in deep waters and not on the surface of oceans and other water bodies.
  • Even when a compound is obtained from a marine source after tackling the challenges, the preservation of the compounds obtained also poses an additional challenge in terms of marine pharmaceutical development.
  • Supply feasibility in an economical and eco-friendly manner for marine-derived pharmaceutical products is another challenge that makes it difficult to maintain a regular supply of marine-derived pharmaceutical compounds. Such increasing challenges will hinder the marine pharmaceuticals market size growth during the forecast period.

This marine pharmaceuticals market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global marine pharmaceuticals market as a part of the global pharmaceuticals market within the overall healthcare market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the marine pharmaceuticals market during the forecast period.

Who are the Major Marine Pharmaceuticals Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Amway Corp.
  • BASF SE
  • BeyondSpring Inc.
  • BioMarin Pharmaceutical Inc.
  • Bristol Myers Squibb Co.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
  • Guardian Industries Corp.
  • Jazz Pharmaceuticals Plc
  • Koninklijke DSM NV
  • Merck KGaA
  • Nordic Naturals Inc.
  • Pelagia EPAX
  • Pfizer Inc.
  • Pharma Marine AS
  • PharmaMar SA
  • Seagen Inc.
  • Croda International Plc

 

This statistical study of the marine pharmaceuticals market encompasses successful business strategies deployed by the key vendors. The marine pharmaceuticals market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • BeyondSpring Inc. - The company offers PLINABULIN which is a cell modulator with potential anticancer and chemotherapy-induced neutropenia prevention benefits. 
  • BioMarin Pharmaceutical Inc. - The company offers the development and commercialization of marine pharmaceutical products for therapies in rare genetic diseases. 
  • Bristol Myers Squibb Co. - The company offers Marizomib which is a potent proteasome inhibitor being studied as a potential anticancer agent. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The marine pharmaceuticals market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Marine Pharmaceuticals Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the marine pharmaceuticals market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Marine Pharmaceuticals Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the marine pharmaceuticals market in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The high prevalence of elevated TG levels will facilitate the marine pharmaceuticals market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic negatively impacted the regional marine pharmaceuticals market. However, in H2 2021, the introduction of COVID-19 vaccines led to a decrease in the number of COVID-19 cases in the region. This has resulted in the resumption of supply chain operations, which has led to the availability of various marine pharmaceutical drugs for the treatment of different forms of carcinoma, pain, and CVD. These factors will drive the growth of the regional marine pharmaceuticals market during the forecast period.

What are the Revenue-generating Product Segments in the Marine Pharmaceuticals Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The marine pharmaceuticals market share growth by the oncology segment will be significant during the forecast period. Cancer is among the most frequent causes of death across the globe. Although tremendous progress is underway in cancer therapy R&D, an urgent need for novel oncology drugs still exists. Moreover, the oncology segment will witness robust growth in the global marine pharmaceuticals market during the forecast period. Thus, the high incidence of various types of cancer across the globe will be the primary driver for the demand for marine oncology products. Thus, the increasing demand of oncology drugs will drive the marine pharmaceuticals market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the marine pharmaceuticals market size and actionable market insights on post COVID-19 impact on each segment.

 

Marine Pharmaceuticals Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.73%

Market growth 2022-2026

$ 1.56 billion

Market structure

Concentrated

YoY growth (%)

5.3

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., and Croda International Plc

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Marine Pharmaceuticals Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive marine pharmaceuticals market growth during the next five years
  • Precise estimation of the marine pharmaceuticals market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the marine pharmaceuticals industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of marine pharmaceuticals market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Oncology - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
    • 5.4 Cardiovascular - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Cardiovascular - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Cardiovascular - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Cardiovascular - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Cardiovascular - Year-over-year growth 2021-2026 (%)
    • 5.5 Anti-infectives - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Anti-infectives - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Anti-infectives - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Anti-infectives - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Anti-infectives - Year-over-year growth 2021-2026 (%)
    • 5.6 Others - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.7 Market opportunity by Product
      • Exhibit 44: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 48: Chart on Geographic comparison
      • Exhibit 49: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 86: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 89: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 90: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 91: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 92: Matrix on vendor position and classification
            • 10.3 BeyondSpring Inc.
              • Exhibit 93: BeyondSpring Inc. - Overview
              • Exhibit 94: BeyondSpring Inc. - Product / Service
              • Exhibit 95: BeyondSpring Inc. - Key offerings
            • 10.4 BioMarin Pharmaceutical Inc.
              • Exhibit 96: BioMarin Pharmaceutical Inc. - Overview
              • Exhibit 97: BioMarin Pharmaceutical Inc. - Product / Service
              • Exhibit 98: BioMarin Pharmaceutical Inc. - Key offerings
            • 10.5 Bristol Myers Squibb Co.
              • Exhibit 99: Bristol Myers Squibb Co. - Overview
              • Exhibit 100: Bristol Myers Squibb Co. - Product / Service
              • Exhibit 101: Bristol Myers Squibb Co. - Key offerings
            • 10.6 Eisai Co. Ltd.
              • Exhibit 102: Eisai Co. Ltd. - Overview
              • Exhibit 103: Eisai Co. Ltd. - Business segments
              • Exhibit 104: Eisai Co. Ltd. - Key offerings
              • Exhibit 105: Eisai Co. Ltd. - Segment focus
            • 10.7 GlaxoSmithKline Plc
              • Exhibit 106: GlaxoSmithKline Plc - Overview
              • Exhibit 107: GlaxoSmithKline Plc - Business segments
              • Exhibit 108: GlaxoSmithKline Plc - Key news
              • Exhibit 109: GlaxoSmithKline Plc - Key offerings
              • Exhibit 110: GlaxoSmithKline Plc - Segment focus
            • 10.8 Jazz Pharmaceuticals Plc
              • Exhibit 111: Jazz Pharmaceuticals Plc - Overview
              • Exhibit 112: Jazz Pharmaceuticals Plc - Product / Service
              • Exhibit 113: Jazz Pharmaceuticals Plc - Key news
              • Exhibit 114: Jazz Pharmaceuticals Plc - Key offerings
            • 10.9 Nordic Naturals Inc.
              • Exhibit 115: Nordic Naturals Inc. - Overview
              • Exhibit 116: Nordic Naturals Inc. - Product / Service
              • Exhibit 117: Nordic Naturals Inc. - Key offerings
            • 10.10 Pfizer Inc.
              • Exhibit 118: Pfizer Inc. - Overview
              • Exhibit 119: Pfizer Inc. - Product / Service
              • Exhibit 120: Pfizer Inc. - Key news
              • Exhibit 121: Pfizer Inc. - Key offerings
            • 10.11 PharmaMar SA
              • Exhibit 122: PharmaMar SA - Overview
              • Exhibit 123: PharmaMar SA - Business segments
              • Exhibit 124: PharmaMar SA - Key news
              • Exhibit 125: PharmaMar SA - Key offerings
              • Exhibit 126: PharmaMar SA - Segment focus
            • 10.12 Seagen Inc.
              • Exhibit 127: Seagen Inc. - Overview
              • Exhibit 128: Seagen Inc. - Product / Service
              • Exhibit 129: Seagen Inc. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 130: Inclusions checklist
                • Exhibit 131: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 132: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 133: Research methodology
                • Exhibit 134: Validation techniques employed for market sizing
                • Exhibit 135: Information sources
              • 11.5 List of abbreviations
                • Exhibit 136: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The marine pharmaceuticals market growth will increase by $1561.69 million during 2022-2026.
              The marine pharmaceuticals market is expected to grow at a CAGR of 7.73% during 2022-2026.
              Technavio has segmented the marine pharmaceuticals market by product (Oncology, Cardiovascular, Anti-infectives, and Others) and geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Amway Corp., BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Guardian Industries Corp., Jazz Pharmaceuticals Plc, Koninklijke DSM NV, Merck KGaA, Nordic Naturals Inc., Pelagia EPAX, Pfizer Inc., Pharma Marine AS, PharmaMar SA, Seagen Inc., Croda International Plc are a few of the key vendors in the marine pharmaceuticals market.
              North America will register the highest growth rate of 38.16% among the other regions. Therefore, the marine pharmaceuticals market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the marine pharmaceuticals market growth are:
              • Licensing agreements
              • Marine peptides as anti-infectives
              The marine pharmaceuticals market vendors should focus on grabbing business opportunities from the oncology segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>